↓ Skip to main content

Regional differences in physicians’ behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study

Overview of attention for article published in Frontiers in Cardiovascular Medicine, June 2023
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
6 Mendeley